{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:56:57Z","timestamp":1792796217475,"version":"4.5.0"},"reference-count":33,"publisher":"China Science Publishing & Media Ltd.","issue":"8","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.1093\/abbs\/gmu044","type":"journal-article","created":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T06:48:28Z","timestamp":1403333308000},"page":"675-681","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":4,"title":["The anorexic effect of Ex4\/Fc through GLP-1 receptor activation in high-fat diet fed mice"],"prefix":"10.3724","volume":"46","author":[{"given":"Rui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongde","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00125-002-0828-3","volume":"45","author":"Wang Q","year":"2002","unstructured":"Wang Q, Brubaker PL. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db\/db mice. Diabetologia, 2002, 45: 1263-1273.","journal-title":"Diabetologia"},{"key":"null","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2362.1997.1490691.x","volume":"27","author":"Todd JF","year":"1997","unstructured":"Todd JF, Wilding JP, Edwards CM, Khan FA, Ghatei MA, Bloom SR. Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus. Eur J Clin Invest, 1997, 27: 533-536.","journal-title":"Eur J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"Drucker DJ","year":"2006","unstructured":"Drucker DJ. The biology of incretin hormones. Cell Metab, 2006, 3: 153-165.","journal-title":"Cell Metab"},{"key":"null","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2337\/dc09-1914","volume":"33","author":"Buse JB","year":"2010","unstructured":"Buse JB, Drucker DJ, Taylor KL, Kim T, Walsh B, Hu H, Wilhelm K. DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks. Diabetes Care, 2010, 33: 1255-1261.","journal-title":"Diabetes Care"},{"key":"null","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.27.11.2628","volume":"27","author":"Buse JB","year":"2004","unstructured":"Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care, 2004, 27: 2628-2635.","journal-title":"Diabetes Care"},{"key":"null","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jgm.1598","volume":"13","author":"Liang Y","year":"2011","unstructured":"Liang Y, Qiu H, Glinka Y, Lazarus AH, Ni H, Prud'homme GJ, Wang Q. Immunity against a therapeutic xenoprotein\/Fc construct delivered by gene transfer is reduced through binding to the inhibitory receptor FcgammaRIIb. J Gene Med, 2011, 13: 470-477.","journal-title":"J Gene Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.gt.3302836","volume":"14","author":"Kumar M","year":"2007","unstructured":"Kumar M, Hunag Y, Glinka Y, Prud'homme GJ, Wang Q. Gene therapy of diabetes using a novel GLP-1\/IgG1-Fc fusion construct normalizes glucose levels in db\/db mice. Gene Ther, 2007, 14: 162-172.","journal-title":"Gene Ther"},{"key":"null","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbrc.2010.10.131","volume":"403","author":"Liu R","year":"2010","unstructured":"Liu R, Li Y, Hu R, Jin T, Deng S, Liang W, Zhang N. A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis. Biochem Biophys Res Commun, 2010, 403: 172-177.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.abb.2005.01.010","volume":"436","author":"Park SY","year":"2005","unstructured":"Park SY, Choi GH, Choi HI, Ryu J, Jung CY, Lee W. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats. Arch Biochem Biophys, 2005, 436: 276-284.","journal-title":"Arch Biochem Biophys"},{"key":"null","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s00125-005-1933-x","volume":"48","author":"Patti ME","year":"2005","unstructured":"Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia, 2005, 48: 2236-2240.","journal-title":"Diabetologia"},{"key":"null","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1210\/endo.141.12.7806","volume":"141","author":"Perfetti R","year":"2000","unstructured":"Perfetti R, Zhou J, Doyle ME, Egan JM. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology, 2000, 141: 4600-4605.","journal-title":"Endocrinology"},{"key":"null","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","volume":"379","author":"Turton MD","year":"1996","unstructured":"Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature, 1996, 379: 69-72.","journal-title":"Nature"},{"key":"null","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L","volume":"172","author":"Montrose-Rafizadeh C","year":"1997","unstructured":"Montrose-Rafizadeh C, Yang H, Wang Y, Roth J, Montrose MH, Adams LG. Novel signal transduction and peptide specificity of glucagon-like peptide receptor in 3T3-L1 adipocytes. J Cell Physiol, 1997, 172: 275-283.","journal-title":"J Cell Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2009.10.015","volume":"390","author":"Chung LTK","year":"2009","unstructured":"Chung LTK, Hosaka T, Yoshida M, Harada N, Sakaue H, Sakai T, Nakaya Y. Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression. Biochem Biophys Res Commun, 2009, 390: 613-618.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/00015550252948149","volume":"82","author":"Lee AY","year":"2002","unstructured":"Lee AY, Chey WY, Choi J, Jeon JS. Insulin-induced drug eruptions and reliability of skin tests. Acta Derm Venereol, 2002, 82: 114-117.","journal-title":"Acta Derm Venereol"},{"key":"null","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/039463200401700105","volume":"17","author":"Ahangari G","year":"2004","unstructured":"Ahangari G, Ostadali MR, Rabani A, Rashidian J, Sanati MH, Zarindast MR. Growth hormone antibodies formation in patients treated with recombinant human growth hormone. Int J Immunopathol Pharmacol, 2004, 17: 33-38.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"null","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","volume":"374","author":"Buse JB","year":"2009","unstructured":"Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet, 2009, 374: 39-47.","journal-title":"Lancet"},{"key":"null","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2337\/diacare.28.5.1092","volume":"28","author":"DeFronzo RA","year":"2005","unstructured":"DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care, 2005, 28: 1092-1100.","journal-title":"Diabetes Care"},{"key":"null","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diacare.28.5.1083","volume":"28","author":"Kendall DM","year":"2005","unstructured":"Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care, 2005, 28: 1083-1091.","journal-title":"Diabetes Care"},{"key":"null","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/dc11-0931","volume":"35","author":"Dushay J","year":"2012","unstructured":"Dushay J, Gao C, Gopalakrishnan GS, Crawley M, Mitten EK, Wilker E, Mullington J. Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes. Diabetes Care, 2012, 35: 4-11.","journal-title":"Diabetes Care"},{"key":"null","doi-asserted-by":"crossref","first-page":"e34289","DOI":"10.1371\/journal.pone.0034289","volume":"7","author":"Marchal J","year":"2012","unstructured":"Marchal J, Blanc S, Epelbaum J, Aujard F, Pifferi F. Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus. PLoS ONE, 2012, 7:","journal-title":"PLoS ONE"},{"key":"null","doi-asserted-by":"crossref","first-page":"R1061","DOI":"10.1152\/ajpregu.00438.2009","volume":"298","author":"Riediger T","year":"2010","unstructured":"Riediger T, Eisele N, Scheel C, Lutz TA. Effects of glucagon-like peptide 1 and oxyntomodulin on neuronal activity of ghrelin-sensitive neurons in the hypothalamic arcuate nucleus. Am J Physiol Regul Integr Comp Physiol, 2010, 298: R1061-R1067.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.2337\/diabetes.53.9.2492","volume":"53","author":"Baggio LL","year":"2004","unstructured":"Baggio LL, Huang Q, Brown TJ, Drucker DJ. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes, 2004, 53: 2492-2500.","journal-title":"Diabetes"},{"key":"null","doi-asserted-by":"crossref","first-page":"F137","DOI":"10.1152\/ajprenal.00064.2012","volume":"304","author":"Thomson SC","year":"2013","unstructured":"Thomson SC, Kashkouli A, Singh P. Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat. Am J Physiol Renal Physiol, 2013, 304: F137-FF44.","journal-title":"Am J Physiol Renal Physiol"},{"key":"null","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.2337\/diabetes.50.11.2530","volume":"50","author":"Larsen PJ","year":"2001","unstructured":"Larsen PJ, Fledelius C, Knudsen LB, Tang-Christensen M. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes, 2001, 50: 2530-2539.","journal-title":"Diabetes"},{"key":"null","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.regpep.2004.01.003","volume":"119","author":"Lippl F","year":"2004","unstructured":"Lippl F, Kircher F, Erdmann J, Allescher HD, Schusdziarra V. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Regul Pept, 2004, 119: 93-98.","journal-title":"Regul Pept"},{"key":"null","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.peptides.2006.10.014","volume":"28","author":"Brennan IM","year":"2007","unstructured":"Brennan IM, Otto B, Feltrin KL, Meyer JH, Horowitz M, Feinle-Bisset C. Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men. Peptides, 2007, 28: 607-611.","journal-title":"Peptides"},{"key":"null","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.regpep.2007.03.002","volume":"143","author":"Hagemann D","year":"2007","unstructured":"Hagemann D, Holst JJ, Gethmann A, Banasch M, Schmidt WE, Meier JJ. Glucagon-like peptide 1 (GLP-1) suppresses ghrelin levels in humans via increased insulin secretion. Regul Pept, 2007, 143: 64-68.","journal-title":"Regul Pept"},{"key":"null","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1172\/JCI43703","volume":"121","author":"Scott MM","year":"2011","unstructured":"Scott MM, Williams KW, Rossi J, Lee CE, Elmquist JK. Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice. J Clin Invest, 2011, 121: 2413-2421.","journal-title":"J Clin Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s005920050079","volume":"34","author":"Drewes C","year":"1997","unstructured":"Drewes C, Nauck MA, Horn R, Holst J, Schmiegel W, Brabant G. A liquid mixed meal or exogenous glucagon-like peptide 1 (GLP-1) do not alter plasma leptin concentrations in healthy volunteers. Acta Diabetol, 1997, 34: 230-234.","journal-title":"Acta Diabetol"},{"key":"null","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.ijo.0802640","volume":"28","author":"Perreault M","year":"2004","unstructured":"Perreault M, Istrate N, Wang L, Nichols AJ, Tozzo E, Stricker-Krongrad A. Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. Int J Obes Relat Metab Disord, 2004, 28: 879-885.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"null","doi-asserted-by":"crossref","first-page":"e6884","DOI":"10.1371\/journal.pone.0006884","volume":"4","author":"Jiang L","year":"2009","unstructured":"Jiang L, Wang Q, Yu Y, Zhao F, Huang P, Zeng R, Qi RZ. Leptin contributes to the adaptive responses of mice to high-fat diet intake through suppressing the lipogenic pathway. PLoS ONE, 2009, 4:","journal-title":"PLoS ONE"},{"key":"null","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cmet.2007.02.004","volume":"5","author":"Enriori PJ","year":"2007","unstructured":"Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, Billes SK, Glavas MM. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab, 2007, 5: 181-194.","journal-title":"Cell Metab"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/CF316309BD0B4425A0147833E4BF14CB","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmu044","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/CF316309BD0B4425A0147833E4BF14CB","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T13:34:25Z","timestamp":1689341665000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmu044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,1]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmu044","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8,1]]}}}